Company Filing History:
Years Active: 2011-2012
Title: Bernard Leclerc: Innovator in Low-Dose Tablet Technology
Introduction
Bernard Leclerc is a notable inventor based in Igny, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of low-dose tablets. With a total of 2 patents, his work focuses on innovative methods for delivering active substances effectively.
Latest Patents
Leclerc's latest patents include two groundbreaking inventions related to low-dose tablets. The first patent describes a microgranule tablet that comprises a low dose of active principle, utilizing a directly compressible diluent made exclusively of neutral microgranules. This invention is characterized by the fact that the active principle is set on the neutral microgranules without any coating agents that modify its release or mask its taste. The second patent involves low-dose tablets obtained through direct compression of microgranules, which are primarily composed of a neutral support covered by a polymeric layer. This layer contains at least one pharmaceutically acceptable polymer that allows for the modified release of active substances in an aqueous medium. The tablets exhibit a matrix effect similar to conventional matrix tablets, enabling a tailored release profile based on the type of polymer used.
Career Highlights
Bernard Leclerc is associated with Ethypharm, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the technology behind low-dose medications, making them more effective and patient-friendly.
Collaborations
Leclerc collaborates with Guy Couaraze, contributing to the development of innovative pharmaceutical solutions.
Conclusion
Bernard Leclerc's contributions to low-dose tablet technology highlight his role as a key innovator in the pharmaceutical industry. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients worldwide.